⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FLNA News
Filana Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
FLNA
Form 8-K
sec.gov
FLNA
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
globenewswire.com
FLNA
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
globenewswire.com
FLNA
Form 8-K
sec.gov
FLNA
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
globenewswire.com
FLNA
Form 8-K
sec.gov
FLNA
SAVA
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
globenewswire.com
FLNA
SAVA